Strength
500 mg/10mL
Manufacturer
Xellia Pharmaceuticals USA LLCNDC
70594006001
Classification
Generic
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Last Updated
1/21/2026
Active Ingredients
DAPTOMYCINApproval Type
New Drug (NDA)
FDA Application
NDA217415On Market Since
11/3/2023
Pharmacological Classes
Lipopeptide Antibacterial
Lipopeptides
Related Drugs
Same classification
DAPTOMYCIN 350 MG VIAL
Generic
00409012001•Hospira Inc.
$13.4180
per EA
DAPTOMYCIN 350 MG VIAL
Generic
16729043405•Accord Healthcare Inc.
$13.4180
per EA
DAPTOMYCIN 350 MG VIAL
Generic
25021017915•Sagent Pharmaceuticals
$13.4180
per EA
DAPTOMYCIN 350 MG VIAL
Generic
25021017966•Sagent Pharmaceuticals
$13.4180
per EA
DAPTOMYCIN 350 MG VIAL
Generic
31722021501•Camber Pharmaceuticals Inc.
$13.4180
per EA
DAPTOMYCIN 350 MG VIAL
Generic
43598047611•Dr. Reddy's Laboratories Inc.
$13.4180
per EA
DAPTOMYCIN 350 MG VIAL
Generic
70594005301•Xellia Pharmaceuticals USA LLC
$13.4180
per EA
DAPTOMYCIN 350 MG VIAL
Generic
71288001715•Meitheal Pharmaceuticals Inc.
$13.4180
per EA
DAPTOMYCIN 350 MG VIAL
Generic
71288001791•Meitheal Pharmaceuticals Inc.
$13.4180
per EA
DAPTOMYCIN 350 MG VIAL
Generic
72572010001•Civica, Inc.
$13.4180
per EA